VIVEK JAIN

Dr. VIVEK JAIN


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
APAshutosh Pareek
Ashutosh Pareek
MPMalvika Pant
Malvika Pant
MGMadan Mohan Gupta
Madan Mohan Gupta
PKPushpa Kashania
Pushpa Kashania
YBYashumati Ratan Bhardwaj
Yashumati Ratan Bhardwaj
ACAnil Chuturgoon
Anil Chuturgoon
Moringa oleifera, also known as the “tree of life” or “miracle tree,” is classified as an important herbal plant due to its immense medicinal and non-medicinal benefits. Traditionally, the plant is used to cure wounds, pain, ulcers, liver disease, heart disease, cancer, and inflammation. This review aims to compile an analysis of worldwide research, pharmacological activities, phytochemical, toxicological, and ethnomedicinal updates of Moringa oleifera and also provide insight into its commercial and phytopharmaceutical applications with a motive to help further research. The scientific information on this plant was obtained from various sites and search engines such as Scopus, Pub Med, Science Direct, BMC, Google Scholar, and other scientific databases. Articles available in the English language have only been referred for review. The pharmacological studies confirm the hepatoprotective, cardioprotective, and anti-inflammatory potential of the extracts from the various plant parts. It was found that bioactive constituents are present in every part of the plant. So far, more than one hundred compounds from different parts of Moringa oleifera have been characterized, including alkaloids, flavonoids, anthraquinones, vitamins, glycosides, and terpenes. In addition, novel isolates such as muramoside A&B and niazimin A&B have been identified in the plant and have potent antioxidant, anticancer, antihypertensive, hepatoprotective, and nutritional effects. The traditional and nontraditional use of Moringa, its pharmacological effects and their phytopharmaceutical formulations, clinical studies, toxicity profile, and various other uses are recognized in the present review. However, several traditional uses have yet to be scientifically explored. Therefore, further studies are proposed to explore the mechanistic approach of the plant to identify and isolate active or synergistic compounds behind its therapeutic potential.

7 January 2011 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
AJAmteshwar Singh Jaggi
Amteshwar Singh Jaggi
VJVIVEK JAIN
VIVEK JAIN
NSNirmal Singh
Nirmal Singh

8 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
YBYashumati Ratan Bhardwaj
Yashumati Ratan Bhardwaj
ARAISHWARYA RAJPUT
AISHWARYA RAJPUT
SMSushmita Maleysm
Sushmita Maleysm
APAaushi Pareek
Aaushi Pareek
VJVIVEK JAIN
VIVEK JAIN
GSGurjit Singh
Gurjit Singh
Alzheimer’s disease (AD) is the most prominent neurodegenerative disorder in the aging population. It is characterized by cognitive decline, gradual neurodegeneration, and the development of amyloid-β (Aβ)-plaques and neurofibrillary tangles, which constitute hyperphosphorylated tau. The early stages of neurodegeneration in AD include the loss of neurons, followed by synaptic impairment. Since the discovery of AD, substantial factual research has surfaced that outlines the disease’s causes, molecular mechanisms, and prospective therapeutics, but a successful cure for the disease has not yet been discovered. This may be attributed to the complicated pathogenesis of AD, the absence of a well-defined molecular mechanism, and the constrained diagnostic resources and treatment options. To address the aforementioned challenges, extensive disease modeling is essential to fully comprehend the underlying mechanisms of AD, making it easier to design and develop effective treatment strategies. Emerging evidence over the past few decades supports the critical role of Aβ and tau in AD pathogenesis and the participation of glial cells in different molecular and cellular pathways. This review extensively discusses the current understanding concerning Aβ- and tau-associated molecular mechanisms and glial dysfunction in AD. Moreover, the critical risk factors associated with AD including genetics, aging, environmental variables, lifestyle habits, medical conditions, viral/bacterial infections, and psychiatric factors have been summarized. The present study will entice researchers to more thoroughly comprehend and explore the current status of the molecular mechanism of AD, which may assist in AD drug development in the forthcoming era.

1 June 2009 in Pharmacological Research
Verified
Journal Article
Closed access
VJVIVEK JAIN
VIVEK JAIN
AJAmteshwar Singh Jaggi
Amteshwar Singh Jaggi
NSNirmal Singh
Nirmal Singh

2 March 2016 in Nutritional Neuroscience
Verified
Journal Article
Closed access
BVBharat Vashistha
Bharat Vashistha
ASAbhisheak Sharma
Abhisheak Sharma
VJVIVEK JAIN
VIVEK JAIN
The present study was designed to investigate the effect of ferulic acid (FA) in vincristine-induced neuropathic pain in rats. Vincristine (50 µg/kg, i.p. for 10 consecutive days) was administered to induce painful neuropathy in rats. Various pain sensitive tests, viz., pinprick, hot plate, paint-brush, and acetone test were performed on different days (1, 6, 14, and 21) to assess the degree of mechanical hyperalgesia, heat hyperalgesia, mechanical dynamic allodynia, and cold allodynia, respectively. The electrophysiological and histopathological evaluations were also investigated. The tissue thiobarbituric acid reactive species (TBARS), reduced glutathione (GSH), myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), interleukin-10 (IL-10), and total calcium were measured as the markers of inflammation and oxidative stress. FA (50 and 100 mg/kg, i.p.) and gabapentin (10 mg/kg, p.o.) were administered for 11 days. Administration of FA attenuated the vincristine-induced behavioral alteration along with electrophysiological and histopathological changes significantly (P < 0.05). FA also attenuated the vincristine-induced oxidative stress (TBARS, GSH, and total calcium levels) and inflammation (MPO, TNF-alpha, IL-6, and IL-10). It may be concluded that FA has ameliorative potential in mitigation of the painful states associated with vincristine-induced painful neuropathy that may further be attributed to anti-inflammatory actions with subsequent reduction in oxidative stress.

1 January 2022 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
PKParveen Kumar
Parveen Kumar
NYNishant Yadav
Nishant Yadav
BCBenu Chaudhary
Benu Chaudhary
VJVIVEK JAIN
VIVEK JAIN
VBVishal M. Balaramnavar
Vishal M. Balaramnavar
MGMadan Mohan Gupta
Madan Mohan Gupta